- Patent Title: Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
-
Application No.: US16853168Application Date: 2020-04-20
-
Publication No.: US10940117B2Publication Date: 2021-03-09
- Inventor: Sami Karaborni , Sarina Grace Harris Ma , Chen Mao , Ching Wah Chong , Peter Robert Prinz Freed , Mesut Ciper , Stefanie Krenzlin , David J. Wustrow , Peter A. Virsik
- Applicant: ARBOR PHARMACEUTICALS, LLC
- Applicant Address: US GA Atlanta
- Assignee: ARBOR PHARMACEUTICALS, LLC
- Current Assignee: ARBOR PHARMACEUTICALS, LLC
- Current Assignee Address: US GA Atlanta
- Agency: King & Spalding
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/16 ; A61K9/20 ; A61K31/225 ; A61K31/215 ; A61K31/27 ; A61K31/5375 ; A61K9/14 ; A61K9/48
Abstract:
Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclose.
Public/Granted literature
- US20200246271A1 ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF Public/Granted day:2020-08-06
Information query
